Prophylactic strategies, including long-acting granulocyte colony-stimulating factor (G-CSF), trimethoprim–sulfamethoxazole, and acyclovir, have been advocated to reduce febrile neutropenia and opportunistic infections in high-risk lymphoma patients [29]. Here, CSF3 is linked to Opportunistic infection.